List view / Grid view
Obesity is associated with reduced muscle mass and impaired metabolism. Epigenetic changes that affect the formation of new muscle cells may be a contributing factor, according to new research from Lund University, Sweden.
Autonomous driving, automatic speech recognition, and the game Go: Deep Learning is generating more and more public awareness.
Stem cells are among the most energetically activated, migratory and proliferative sub-populations of tumour cells, according to observations by scholars at the Biomedical Research Centre at the University of Salford.
Christian Andersson, Product Development Manager at Takara Bio discusses hiPS-derived beta cells, which offer an unprecedented opportunity for diabetes research to model human physiology and ‘diseases in a dish’. Christian looks into the potential for new discoveries for diabetes and other metabolic diseases...
The collaboration will combine Immatics’ Xpresident target discovery and T-cell receptor (TCR) capabilities with Amgen’s validated Bispecific T-cell Engager (BiTE) technology with the aim of creating novel oncology drugs.
12 January 2017 | By ProteinSimple
Single-Cell Western system capable of analysing protein expression in ~1,000 single-cells in parallel to unlock heterogeneity...
The outlook for brain tumour patients is pretty negative, with the median survival rate for patients with glioblastoma multiforme, or GBM, a mere 14.2 months.
A new study led by scientists at the Scripps Research Institute (TSRI) sheds light on how the brain stores memories.
Mission Therapeutics have appointed Dr Colin Goddard as non-executive Chairman, effective January 1st 2017.
NGS technologies have been employed in a wide range of areas in drug discovery, including drug target identification, biomarker discovery and biopharmaceutics development. Pushpanathan Muthuirulan of the National Institutes of Health gives us an overview of this in his article in our NGS In-Depth Focus. Meanwhile, the possibilities that RNA-Seq…
2 December 2016 | By Niamh Louise Marriott, Digital Editor
These systems will allow researchers worldwide to rapidly and accurately explore the changing role of genes as the cells develop into tissues...
2 December 2016 | By Niamh Louise Marriott, Digital Editor
Under the terms of the licence agreement, Oxford BioMedica has granted an exclusive intellectual property licence to Orchard for collaboration programmes...
29 November 2016 | By SMi Group
Pharmaceutical Microbiology 2017 will bring together MHRA, Paul Ehrilch Institut, Sanofi, Lonza, Steris, Pfizer and many more to explore the topics of contamination and endotoxins, quality assurance and control, environmental monitoring, new mechanisms of detection and the newly added topic of pharmaceutical water systems...
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Cell Medica has expanded its partnership with Baylor College of Medicine to develop an off-the-shelf allogeneic cell therapy, using T (NKT) cells...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The ethics of three parent babies has been widely debated - should it be used to save children from deadly mitochondrial diseases or are scientists "playing God"? Here's everything you need to know to decide...
